Kumamoto City Hospital
Kumamoto, Japan
General hospital in Kumamoto
4 Chome-1-60 Higashimachi, Higashi Ward, Kumamoto, 862-8505
About Kumamoto City Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Pfizer
2
Puma Biotechnology, Inc.
2
Eli Lilly and Company
1
Hoffmann-La Roche
1
Clinical Trials at Kumamoto City Hospital
During the past decade, Kumamoto City Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer
2012-10-19
2018-10-25
Completed
61
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
2019-09-05
2027-06-28
Recruiting
286
Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine
2019-07-19
2027-05-05
Recruiting
456
A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
2019-05-31
2020-06-08
Completed
846
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kumamoto City Hospital" #1 sponsor was "Amgen" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kumamoto City Hospital"
#1 collaborator was "Novartis" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kumamoto City Hospital
According to Clinical.Site data, the most researched conditions in "Kumamoto City Hospital" are
"Migraine" (3 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Advanced Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Kumamoto City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kumamoto City Hospital
Most popular intervention types in "Kumamoto City Hospital" are "Drug" (8 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "PD-0332991" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kumamoto City Hospital
The vast majority of trials in "Kumamoto City Hospital" are
5 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Kumamoto City Hospital
Currently, there are NaN active trials in "Kumamoto City Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Kumamoto City Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kumamoto City Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".